Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings – The American Journal of Emergency Medicine Related: Clinical update on COVID-19 for the emergency and critical care clinician: Medical management – American Journal of Emergency Medicine Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation – […]
The post Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings. appeared first on Links Medicus.
Antithrombotic Therapy for Venous Thromboembolism – JAMA (free for a limited period) Original Guideline: Antithrombotic Therapy for VTE Disease Second Update of the CHEST Guideline and Expert Panel Report
The post Guideline Synopsis: Antithrombotic therapy for venous thromboembolism. appeared first on Links Medicus.
Molecular diagnostics in severe pneumonia: a new dawn or false promise? – Intensive Care Medicine Commentary on Twitter Pneumonia? no gold standard diagnosis available, likely resulting in overtreatment. Molecular diagnostics more widely available even if interpretation/use complex, requiring to take into account data/characteristics when making decisions based on these.? https://t.co/mae0vxBfkF pic.twitter.com/bbkxGLEumN — Intensive Care […]
The post Molecular diagnostics in severe pneumonia: a new dawn or false promise? appeared first on Links Medicus.
International evidence-based recommendations for point-of-care lung ultrasound – Intensive Care Medicine (if the link is paywalled, try this one)
The post International evidence-based recommendations for point-of-care lung ultrasound. appeared first on Links Medicus.
Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial – Intensive Care Medicine (free article here) Commentary on Twitter ? 8 vs 15 days ABT for Pseudomonas aeruginosa VAP in adults, iDIAPASON RCT: no differences in composite or separate outcomes (90-day mortality/VAP recurrence) between short […]
The post RCT: Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults. appeared first on Links Medicus.
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis – New England Journal of Medicine (link to abstract – $ for full-text) Commentary on Twitter In a placebo-controlled trial, treatment with the phosphodiesterase 4 inhibitor BI 1015550 prevented a decrease in lung function over a 12-week period in patients with idiopathic pulmonary […]
The post Trial of a preferential Phosphodiesterase 4B Inhibitor for idiopathic pulmonary fibrosis. appeared first on Links Medicus.
Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma – New England Journal of Medicine (link to abstract – $ for full-text) Commentary on Twitter The risk of severe asthma exacerbation was significantly lower with as-needed use of a fixed-dose combination of 180 μg of albuterol and 160 μg of budesonide than with albuterol alone. #ATS2022 […]
The post RCT: Albuterol–budesonide fixed-dose combination rescue inhaler for asthma. appeared first on Links Medicus.
Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial – JAMA Related: Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled Trial – JAMA Internal Medicine Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic […]
The post RCT: Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure. appeared first on Links Medicus.
Long Covid: A Systematic Review and Meta-Analysis of 120,970 Patients – Preprints with The Lancet Commentary on Twitter A systematic #LongCovid review of nearly 200 studies and over 120,000 participants, reinforces the high frequency of symptoms > 6 months, not linked to severity of acute illness, and potential for marked disabilityhttps://t.co/9NYQT1P79G pic.twitter.com/WFzBqghbGI — Eric […]
The post [Preprint] Long Covid: A systematic review and meta-analysis of 120,970 patients. appeared first on Links Medicus.
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study – The Lancet Respiratory Medicine News Release: Two years after infection, half of people hospitalized with COVID-19 have at least one symptom, follow-up study suggests – Lancet
The post Cohort Study: Health outcomes in people 2 years after surviving hospitalization with COVID-19. appeared first on Links Medicus.